Patients with migraines looking for alternative treatments are increasingly turning to cannabis, especially since available medications are not always effective. In response to the growing demand, scientists are intensively researching the effects of cannabis and its components, such as THC and CBD, in the context of migraine treatment. Here's a summary of 8 recent studies on its effectiveness.
Migraine is a type of headache often described as a throbbing pain on one side of the head. While the causes of migraines are not entirely known, it is understood that they are often associated with various factors, such as stress, hormonal changes, and certain foods.
Migraine is not merely a “common headache” — it’s a neurological disease that can impact a person’s daily life. Migraine attacks can last from a few hours to several days and are often accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound.
For more cannabis research news like this, along with the latest in legalization and lifestyle, download our free cannabis news app.
In recent years, we have observed a significant increase in interest in using cannabis for medical purposes. Thanks to legalization in many countries and states, as well as a growing number of studies confirming its potential therapeutic benefits, medical cannabis is gaining popularity as an alternative to traditional treatment methods for various conditions, including migraines. Patients with migraines who are looking for alternative treatments are increasingly turning to the healing potential of cannabis, especially since currently available medications are not always effective and can cause unwanted side effects. In response to the growing demand, scientists are intensively researching the effects of cannabis and its components, such as THC and CBD, in the context of migraine treatment.
The main objective of this article is to provide readers with reliable information on the potential of medical cannabis in treating migraines and headaches. We aim to present the latest research and scientific evidence concerning its efficacy, dosage, and the potential benefits and risks associated with its use. The article also aims to answer the most frequently asked questions from patients and to dispel any doubts that individuals considering medical cannabis as one of their therapeutic options may have.
Migraine is one of the most common neurological disorders in the world, and its causes are manifold. One of the main risk factors is genetics. Studies show that individuals who have a family member suffering from migraines are significantly more likely to develop the condition. However, genetics is just one of many risk factors and doesn’t always guarantee that the condition will occur.
Migraine is not limited to severe headache pain. It is a complex condition that can manifest with multiple symptoms. The most common symptoms of migraine include:
Migraine significantly impacts the quality of life of those suffering from the condition. Attacks can last from a few hours to even several days, rendering normal functioning impossible. People with migraines often have to give up work, social activities, or spending time with family. These symptoms also lead to feelings of frustration, depression, and isolation. Many patients also report difficulties in establishing and maintaining personal relationships due to regular attacks and the need to avoid potential migraine triggers, such as stress, certain foods, or weather changes.
The endocannabinoid system (ECS) is a network of receptors and ligands located throughout the body that plays a key role in regulating various physiological functions, including pain, appetite, sleep, and stress response. Compounds found in cannabis, particularly THC (tetrahydrocannabinol) and CBD (cannabidiol), interact with this system, modifying its activity. This benefits people suffering from migraines, as medical cannabis can alleviate symptoms associated with this condition.
One of the most well-known effects of cannabis is its ability to relieve pain. Cannabinoids, especially THC, act on receptors in the brain to inhibit pain transmission. For many patients suffering from migraines, medical cannabis is more effective than traditional painkillers, and its action is quicker and more enduring.
Nausea is a common symptom accompanying migraine attacks. THC is a known antiemetic, often used in treating cancer patients undergoing chemotherapy. It works by interacting with receptors in the brain responsible for controlling vomiting and nausea, providing relief to people suffering from migraines.
Insomnia and sleep issues are often associated with migraines. Cannabidiol (CBD) is one of the main components of medical cannabis, known for its calming properties and improving sleep quality. Many patients with migraines have noticed improvements in sleep duration and quality after using CBD-based products, which further helps in alleviating migraine symptoms.
The endocannabinoid system (ECS) is a network of receptors and ligands located throughout the body that plays a key role in regulating various physiological functions, including pain, appetite, sleep, and stress response. Compounds found in cannabis, particularly THC (tetrahydrocannabinol) and CBD (cannabidiol), interact with this system, modifying its activity. This benefits people suffering from migraines, as medical cannabis can alleviate symptoms associated with this condition.
One of the most well-known effects of cannabis is its ability to relieve pain. Cannabinoids, especially THC, act on receptors in the brain to inhibit pain transmission. For many patients suffering from migraines, medical cannabis is more effective than traditional painkillers, and its action is quicker and more enduring.
Nausea is a common symptom accompanying migraine attacks. THC is a known antiemetic, often used in treating cancer patients undergoing chemotherapy. It works by interacting with receptors in the brain responsible for controlling vomiting and nausea, providing relief to people suffering from migraines.
Insomnia and sleep issues are often associated with migraines. Cannabidiol (CBD) is one of the main components of medical cannabis, known for its calming properties and improving sleep quality. Many patients with migraines have noticed improvements in sleep duration and quality after using CBD-based products, which further helps in alleviating migraine symptoms.
In the context of using medical cannabis for treating migraines and headaches, research in recent years has yielded many interesting findings. Below are some of the most important ones.
Experts in the field of medicine and pharmacology are divided on the issue of using medical cannabis in treating migraines. However, the results of the above studies and increasing anecdotal evidence point to potential benefits of its use.
Many specialists in neurology and headache medicine agree that medical cannabis may be a valuable treatment option for some patients, especially those who do not respond to traditional treatment methods. However, they also emphasize the need for further research to confirm its effectiveness and determine the optimal doses and methods of administration.
The appropriate dosage of medical cannabis for treating migraines varies from patient to patient. Many experts recommend starting with low doses and gradually increasing them until optimal effects are achieved. Dosage also depends on the form of administration as well as the concentrations of THC and CBD in the product. Consultation with a medical specialist is always advised before beginning treatment with medical cannabis.
Medical cannabis is available in various forms, including:
Medical cannabis is gaining increasing recognition as an alternative method for treating migraines. Its use comes with both numerous benefits and potential risks.
Although existing studies provide valuable information about the potential benefits of using medical cannabis for migraine treatment, many areas still require further research. Specifically needed are:
We hope that future studies will provide more specific guidelines for patients and doctors, helping to better understand the therapeutic potential of cannabis in the context of migraines.
—
(Featured image by Kendel Media via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…